recent post

KIMS Hospitals signs MoU with Intuitive

October 4, 2024
recent post

Centre for Dental Education & Research organises conclave on oral health

recent post

Turbostart leads $­­1 M investment in Ai Health Highway

recent post

CCI approves acquisition of Bharat Serums and Vaccinesby Mankind Pharma

recent post

CDSCO becomes Affiliate Member of the International Medical Device Regulators Forum

imt Logo cross btn

Alembic Pharma posts Rs 293 crore net profit in Q3

Alembic Pharma posts Rs 293 crore net profit in Q3

The consolidated revenue from operations of the company stood at Rs 1,314.33 crore for the quarter under consideration Alembic Pharmaceuticals reported a 24.92 per cent rise in its consolidated net profit to Rs 292.57 crore for the December quarter mainly on account of robust sales. The company had posted a net profit of Rs 234.19 crore for the corresponding period of the previous financial year, Alembic Pharmaceuticals said in a regulatory filing. The consolidated revenue from operations of the company stood at Rs 1,314.33 crore for the quarter under consideration. It was Rs 1,209.13 crore for the same period a year ago, it added. "It was another good quarter for the company led by strong growth in the India formulation business. The API Business continued to perform well in the current quarter," Pranav Amin, MD, Alembic Pharmaceuticals.

PTI